Sector portfolio · Corporate investor · United States
AbbVie's Biotech portfolio
AbbVie has backed 31 Biotech startups in rounds we track, $2.3B between them, shown by the stage each has reached. The best-funded is Morphic Therapeutic.
31startups backed
4stages
$2.3Braised between them
Series Abiggest stage
Series A
14
Funding by segment
- Series A$919M14
- Series C and later$902M7
- Stage not reported$229M7
- Series B$233M3
Where they are based
- United States28$2.0B
- United Kingdom2$83M
- Netherlands1$189M
United States
United Kingdom
NetherlandsFounded
3Earlier
112
113
214
215
516
417
318
19
220
121
22
23
24
125
26
6 without a founding year on record.
Total raised
- Under $1M1
- $1M to $10M4
- $10M to $50M8
- $50M to $250M17
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
25 of 31 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States28
- United Kingdom2
- Netherlands1
Startups by country, 3 countries in all.
Segment by segment
Series A
14 startups · $919M raised
Morphic TherapeuticMorphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.United States$328MCaribou BiosciencesCaribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.United States$139M
Faze MedicinesFaze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$81M
Light Horse TherapeuticsLight Horse Therapeutics, Inc.United States$62M
CarismaCarisma is a provider of outsourced managed IT services.United States$53M- JJnanaUnited States$50M
Quentis TherapeuticsQuentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases.United States$49M- PPalleonUnited States$48M
Series C and later
7 startups · $902M raised
AlectorAlector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases.United States$215M
AM PharmaAM-Pharma is a Dutch clinical-stage biopharmaceutical company founded in 2001 and based in Utrecht, Netherlands.Netherlands$189M
Quanta TherapeuticsQuanta Therapeutics, Inc.United States$127M
Jnana TherapeuticsJnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.United States$107M
Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
Carisma TherapeuticsCarisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.United States$90M
PACT PharmaPACT Pharma is a clinical-stage biopharmaceutical company based in South San Francisco, California, founded in 2016.United States$75M
Stage not reported
7 startups · $229M raised
Syndeio BiosciencesSyndeio Biosciences (from the Ancient Greek word "to connect") is a clinical-stage biotechnology company developing therapies to rUnited States$90M
Ribon TherapeuticsRibon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.United States$90M
Magnolia NeuroSciencesMagnolia Neurosciences is a private drug discovery and development company dedicated to creating innovative neuroprotective mediciUnited States$18M- RTRodeo TherapeuticsRodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.United States$15M
- AAquinnahUnited States$10M
AmbAgon TherapeuticsAmbagon Therapeutics is a biotechnology company focused on developing innovative therapies for challenging protein targets, particUnited States$5.0M
ThirtyFiveBioThirtyFiveBio is a UK-based biotechnology company founded in 2021, focused on developing first-in-class small-molecule inhibitors United Kingdom$306K
Series B
3 startups · $233M raised
Palleon PharmaceuticalsPalleon Pharmaceuticals is a clinical-stage biotechnology company based in Waltham, Massachusetts.United States$100M
ArtiosArtios Pharma Limited is a privately held biotechnology company based in Cambridge, United Kingdom, at the Babraham Research Campus.United Kingdom$83M- PTPrevail TherapeuticsUnited States$50M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names AbbVie as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosCo-investorsWho invests with AbbVie30 co-investorsSector portfolioCoinbase Ventures' Web3 & Crypto portfolio168 startups · $5.7BSector portfolioSalesforce Ventures' AI portfolio115 startups · $181BSector portfolioGoogle Ventures' AI portfolio81 startups · $16BSector portfolioGoogle Ventures' Biotech portfolio74 startups · $12BSector portfolioSamsung Next's AI portfolio72 startups · $9.8B
Raising from investors like AbbVie?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.